Chikungunya fever: How accurate is the clinical-epidemiological diagnosis compared to the gold standard of molecular and serological laboratory diagnosis?

Página do item simplificado
dc.contributor.authorPaula, Hury Hellen Souza de
dc.contributor.authorMartins, André Frederico
dc.contributor.authorChagas, Raphael Rangel das
dc.contributor.authorMoreira, José
dc.contributor.authorAguiar, Renato Santana de
dc.contributor.authorLamas, Cristiane da Cruz
dc.contributor.authorCardozo, Sergian Vianna
dc.date.accessioned2022-09-09T12:45:43Z
dc.date.available2022-09-09T12:45:43Z
dc.date.issued2020
dc.description.abstractObjective To evaluate the accuracy of the current World Health Organization' (WHO) Chikungunya fever (CHIKF) clinical-epidemiological case definition against the gold standard of laboratory diagnosis. Methods This was a prospective study of patients seeking medical care at an Emergency Department in the metropolitan area of Rio de Janeiro, Brazil, from January to June 2018. Clinical features were recorded. Screening for CHIKF was performed using the RT-qPCR and ELISA-IgM antibody assay. Clinical features of CHIKF RT-qPCR/IgM positive cases were compared with those with other febrile illnesses. Results 27,900 ED visits were recorded, of which 172 (0.61 %) patients were screened for arboviral illness. The prevalence of laboratory-confirmed CHIKF (Lab-CHIKF) was 110/172 [64 %]. Chikungunya virus RNA was detected in 92/172 (53.5 %) patients, while in 18/80 (10.5 %), only IgM was positive. Compared to CHIKV-negative subjects, patients with CHIKF presented much earlier after the onset of symptoms (2 [[1], [2], [3], [4]] vs. 3.5 [2.5−5], p = 0.007), and more frequently reported arthritis (61.8 % vs. 33.9 %, p < 0.0001), arthralgia (96.4 % vs. 79 %, p < 0.0001), and conjunctivitis (35.5 % vs. 16.1 %, p = 0.007). After adjustments for other clinical predictors, arthritis/arthralgia [aOR: 6 (95 % CI 1.8–19.7)] and the presence of conjunctivitis [aOR: 2.85 (95 % CI 1.30−6.24] were positively associated with lab-CHIKF. The sensitivity, specificity, positive predictive value, and negative predictive value of the WHO CHIKF clinical case definition was 96.3 %, 20.9 %, 68.3 % and 76.4 %, respectively, and accuracy was 0.69 [AUC: 0.69 (95 % CI 0.61−0.75)]. Conclusion The WHO case definition needs to be improved for better accuracy, especially in areas in epidemics in areas with co-circulation of arboviruses.
dc.identifier.citationPaula HHS, Martins AF, Chagas RR, Moreira J, Aguiar RS, Lamas CC, Cardozo SV. Chikungunya fever: How accurate is the clinical-epidemiological diagnosis compared to the gold standard of molecular and serological laboratory diagnosis? J Clin Virol. 2020 Dec;133:104679
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/224
dc.language.isoen
dc.publisherJournal of Clinical Virology
dc.subjectChikungunya feveren
dc.subjectAccuracyen
dc.subjectCase definitionen
dc.subjectLaboratory diagnosisen
dc.subject.meshProspective Studiesen
dc.subject.meshHumansen
dc.subject.meshClinical Laboratory Techniquesen
dc.subject.meshChikungunya virus / geneticsen
dc.subject.meshChikungunya Fever / epidemiologyen
dc.subject.meshChikungunya Fever / diagnosisen
dc.subject.meshBrazil / epidemiologyen
dc.titleChikungunya fever: How accurate is the clinical-epidemiological diagnosis compared to the gold standard of molecular and serological laboratory diagnosis?
dc.typeArticleen
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
Artigo_Paula HHS et al_2020.pdf
Tamanho:
546.36 KB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição:
Baixar
Coleções
Artigos Mestrado CC